From: Anna V. Baranova Sent: Thursday, October 15, 2015 9:16 AM To: [log in to unmask]; [log in to unmask]; [log in to unmask]; [log in to unmask] Cc: Diane St. Germain; Christopher Ryan Subject: webinar on Personalized Medicine (Dr.Mark Snyder) Dear Students, I recommend you access the recording of this Webinar by Dr. Snyder, a pioneer in the field of Personalized Medicine. It is recommended especially to these of you who plan to continue the career in medicine, clinical research or any other connected area. with best regards, Ancha Online version<http://ts-productinfo.com/c1/1309539/3d2b356df3ba4835/3d2b356df3ba4835/~/-108> | Mobile friendly<http://ts-productinfo.com/c1/1309539/3d2b356df3ba4835/3d2b356df3ba4835/~/-109> [PRECISION MEDICINE]<http://ts-productinfo.com/c/1309539/3d2b356df3ba4835/1> <http://ts-productinfo.com/c/1309539/3d2b356df3ba4835/2> PRECISION MEDICINE: PERSONAL OMICS PROFILE FOR UNDERSTANDING & MANAGING HEALTH AND DISEASE<http://ts-productinfo.com/c/1309539/3d2b356df3ba4835/2> DATE: Friday, 16 October TIMES: * 6 am PST * 4 pm PST RSVP: Register here<http://ts-productinfo.com/c/1309539/3d2b356df3ba4835/3> to attend the webinar. Can't make it? No problem - register and you'll receive a link to the recording. ABOUT THIS EVENT: DNA and RNA sequencing technology and the burgeoning fields of proteomics and metabolomics are transforming our understanding of disease biology. Researchers are now rapidly discovering biomarkers to probe the underlying pathology of a disease and define the dynamic changes that occur during infection. One researcher is at the cutting-edge of this field: Professor Michael Snyder at Stanford University is the first to relate personal genomics to 'omics' activity and interpret the medical relevance. And Professor Snyder should know best: he has been sequencing his genome and routinely drawing his own blood to track the changes in a billion biomarkers; including RNA, proteins, metabolites and antibodies to predict and validate disease risk. In this webinar, Professor Snyder will discuss the profiling of personal transcriptomes, proteomes, cytokines, metabolomes and autoantibodies to create integrative Personal Omics Profiles (iPOP). Professor Snyder will explain how iPOPs can provide critical insight into the causes and development of disease. In this webinar you will learn: * How 'omics' profiling of transcriptomes, proteomes, cytokines, metabolomes and autoantibodies has revealed dynamic and wide ranging variation in the different molecular components that occur during the progression of an infection * How analysis of heteroallelic expression suggests that significant changes in differential allele expression occur in healthy and disease states * How integrated analysis of multi-omic data on coding and gene regulation can lead to enhanced prediction of disease risk SPEAKER: Professor Michael Snyder<http://ts-productinfo.com/c/1309539/3d2b356df3ba4835/4>, Geneticist, Stanford University Michael Snyder received his PhD training at the California Institute of Technology and carried out his postdoctoral training at Stanford University. Since then, Michael Snyder has held several eminent research positions at both Yale and Stanford, and is currently the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine at Stanford University School of Medicine. His laboratory was the first to perform a large-scale functional genomics project in any organism, and currently carries out a variety of projects in the areas of genomics and proteomics both in yeast and humans. These include not only a central role in the ENCODE project, but also the large-scale analysis of proteins using protein microarrays and the global mapping of the binding sites of chromosomal proteins. His laboratory built the first proteome chip for any organism and the first high resolution tiling array for the entire human genome. INTRODUCING THOMSON REUTERS PROJECT NEON: We are building a social networking platform for scientists, researchers and scholars that we can engage with through authoring, commenting, and research collaborations. Please sign in and check it out. We'd like you to complete your profile, browse, comment and set up your own notifications.. And most important give us your feedback! https://projectne.thomsonreuters.com<http://ts-productinfo.com/c/1309539/3d2b356df3ba4835/5> Dr. Ancha Baranova Associate Professor and the Director for the Center for the Study of Chronic Metabolic Diseases School of Systems Biology College of Science George Mason University 4400 University Dr David King Hall MSN3 E1 Fairfax VA USA Phone: 1-571-334-1145 cscmd.cos.gmu.edu